The George Institute For Global Health
Global
United Kingdom
India
China
Australia

China Clinical Control of Dyslipidemia - Goal Attainment Initiative

Project status: 
Archived

Cardiovascular diseases such as heart and kidney diseases, stroke, and death caused by preventable injury are now the number one cause of death in China. Major contributors to chronic diseases such as heart attack, stroke, or diabetes are an unhealthy lifestyle or a poor diet.

Two of the popular villains of poor health and cardiovascular disease are fat and cholesterol, both of which are types of fat cells called lipids. Cholesterol in itself is not bad. In fact, it's essential to help maintain the proper functioning of cells in our body.

However, it's not just the amount of fat we have in our diet, but the kind of fat that we consume. The consumption of saturated and trans fats have the biggest influence on how much cholesterol we have in our blood, and essentially our risk for heart attack or stroke.

Dyslipidemia is a metabolic disorder where the body produces too much or too little cholesterol. This disorder causes more fats to form in the body, while lowering the good cholesterol that the body needs to remain healthy. Without enough good cholesterol cleaning up our blood vessels, more fats will block blood flow to the heart and brain, elevating the risk of a heart attack or stroke.

The effective management of Dyslipidemia is a critical issue for health services around the world. Reducing the number of heart attacks, strokes and other chronic diseases will improve how people live their lives and can ease the overall burden on the health system.

Improving the delivery of healthcare

The China Clinical Control of Dyslipidemia (CCCD) project was established in 2008 to investigate how to close the gap between how doctors are currently treating patients with Dyslipidemia in China, and the treatment that is recommended by the new Chinese Guidelines on Prevention and Control of Dyslipidemia.

An expert committee of renowned specialists from all over China identified 12 gap areas of Dyslipidemia management in China. To increase awareness among clinical health professionals in China, 12 separate papers on each issue are being prepared to illustrate each problem individually. These experts will make specific recommendations on how doctors can help patients with Dyslipidemia reach healthy levels of cholesterol and reduce their risk of cardiovascular disease.  

Changing lives

Empowering doctors to make better decisions with their patients on how to manage Dyslipidemia will prevent more patients from experiencing a heart attack or stroke in the future. Awareness of proper guidelines and treatment for Dyslipidemia will let patients get on with living their lives, without the burden of heart disease.

The CCCD and The George Institute will give patients the opportunity to make more memories with their families. When patients are receiving the most effective treatment possible, they spend less time in the hospital and more quality time with the people who matter most.